Alendronate

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

50 Suppliers, 24 USDMF, 13 CEP/COS, 6 JDMF, 12 EU WC, 13 KDMF, 10 NDC API, 20 Listed Suppliers

DEVELOPMENTS

2 Drug(s) in Development

2 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

DOSSIERs // Finished Dosage Forms

248 Dossiers, 60 FDA Orange Book, 129 Europe, 24 Canada, 6 Australia, 3 South Africa, 26 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 35MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 70MG BASE, TABLET;ORAL - EQ 70MG BASE;2,800 IU, TABLET;ORAL - EQ 70MG BASE;5,600 IU

RELATED EXCIPIENT COMPANIES

Suppliers, 26 Kerry, 18 Roquette, 17 SPI Pharma, 13 Gangwal Healthcare, 12 Microlex e.U, 11 Sigachi Industries, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 7 BASF, 7 DFE Pharma, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 5 Ingredion Pharma Solutions, 5 Gangwal Chemicals, 4 ACG Worldwide, 4 Rochem International Inc, 4 Prachin Chemical, 4 Vasa Pharmachem, 3 Lonza Capsugel, 3 DKSH, 2 Actylis, 2 Pharmatrans-Sanaq, 2 Boai NKY Pharmaceuticals Ltd, 2 Pfanstiehl, 1 Ulanqab Kema New Material, 1 Qualicaps, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Seppic, 1 Pharm-RX Chemical, 1 Bioplus Life Sciences, 1 Ideal Cures Pvt Ltd, 1 Jai Radhe Sales, 1 Nanjing Well Pharmaceutical

EXCIPIENTS BY APPLICATIONS

71 Fillers, Diluents & Binders, 33 Direct Compression, 27 Disintegrants & Superdisintegrants, 24 Taste Masking, 18 Granulation, 16 Co-Processed Excipients, 15 Thickeners and Stabilizers, 14 Chewable & Orodispersible Aids, 14 Lubricants & Glidants, 8 Coating Systems & Additives, 8 Empty Capsules, 6 Controlled & Modified Release, 4 Parenteral, 4 API Stability Enhancers, 3 Topical, 2 Solubilizers, 2 Rheology Modifiers, 2 Emulsifying Agents, 1 Film Formers & Plasticizers

GLOBAL SALES INFORMATION

32 US Medicaid Prescriptions, 144 Finished Drug Prices

MARKET PLACE

10 APIs, 1 DOSSIERS // FDF

PATENTS

1 US Patents, 17 Health Canada Patents

ANALYTICAL SOLUTION(s)

1 BioAnalytical Methods, 2 EDQM Standards, 1 USP Standards, 4 JP Standards, 1 Other Ref. Standards

DIGITAL CONTENT

4 Data Compilation & Company Tracker #PharmaFlow, 24 News

Latest U.S. Prescription Data for Drugs containing Alendronate under Medicare's Part D Prescription Drug Program. Original Data: Centers for Medicare & Medicaid Services Website

Alendronate

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

50 Suppliers

24 USDMF

13 CEP/COS

6 JDMF

12 EU WC

13 KDMF

10 NDC API

20 Listed Suppliers

DEVELOPMENTS

2 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

DOSSIERs // Finished Dosage Forms

248 Dossiers

60 FDA Orange Book

129 Europe

24 Canada

6 Australia

3 South Africa

26 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 35MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 40MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 70MG BASE

TABLET;ORAL - EQ 70MG BASE;2,800 IU

TABLET;ORAL - EQ 70MG BASE;5,600 IU

RELATED EXCIPIENT COMPANIES

Suppliers

26 Kerry

18 Roquette

17 SPI Pharma

13 Gangwal Healthcare

12 Microlex e.U

11 Sigachi Industries

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

7 BASF

7 DFE Pharma

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

5 Ingredion Pharma Solutions

5 Gangwal Chemicals

4 ACG Worldwide

4 Rochem International Inc

4 Prachin Chemical

4 Vasa Pharmachem

3 Lonza Capsugel

3 DKSH

2 Actylis

2 Pharmatrans-Sanaq

2 Boai NKY Pharmaceuticals Ltd

2 Pfanstiehl

1 Ulanqab Kema New Material

1 Qualicaps

1 Shijiazhuang Huaxu Pharmaceutical

1 Shanghai Welltone Material Technology Co., Ltd

1 Seppic

1 Pharm-RX Chemical

1 Bioplus Life Sciences

1 Ideal Cures Pvt Ltd

1 Jai Radhe Sales

1 Nanjing Well Pharmaceutical

EXCIPIENTS BY APPLICATIONS

71 Fillers, Diluents & Binders

33 Direct Compression

27 Disintegrants & Superdisintegrants

24 Taste Masking

18 Granulation

16 Co-Processed Excipients

15 Thickeners and Stabilizers

14 Chewable & Orodispersible Aids

TABLET;ORAL - EQ 10MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 35MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 40MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons